ArticleCureus2026
Paradoxical Acute Hypoxemic Deterioration During Treatment of Bilateral Bronchopneumonia: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Community-acquired pneumonia may occasionally be associated with unexpected respiratory deterioration despite apparent clinical, laboratory, and radiological improvement. We report a case of a previously healthy adult male who presented with progressive dyspnea, persistent cough, generalized weakness, malaise, and low-grade fever. Initial chest radiography showed no significant abnormalities despite marked respiratory symptoms, whereas chest computed tomography revealed bilateral bronchopneumonia with multiple centrilobular nodules and patchy ground-glass opacities. The patient was treated with intravenous meropenem, systemic corticosteroids, inhaled therapy, supplemental oxygen, and supportive care, with gradual improvement in inflammatory markers. On hospital day three, however, he developed sudden severe hypoxemic respiratory failure shortly after antimicrobial administration, requiring intensive care unit admission and high-flow nasal cannula oxygen therapy. Urgent CT pulmonary angiography excluded pulmonary embolism, follow-up imaging demonstrated partial regression of the pulmonary infiltrates, and cardiological evaluation showed no evidence of acute cardiac pathology. Meropenem was replaced with levofloxacin because a drug-related reaction could not be completely excluded. The patient's respiratory status subsequently improved rapidly with supportive treatment, and he was discharged without residual respiratory insufficiency. This case demonstrates that severe transient hypoxemic deterioration may occur during apparently successful treatment of bilateral bronchopneumonia and emphasizes the importance of promptly excluding pulmonary embolism, acute cardiac disease, drug-related reactions, and other potentially life-threatening causes of respiratory worsening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.